{"result": "(\"entity\"<|>HIPONATREMIA<|>EVENT<|>Hiponatremia is a medical condition characterized by low sodium levels in the blood, which can lead to neurological symptoms and requires careful treatment management.)\n##\n(\"entity\"<|>NUTRICIÓN ARTIFICIAL<|>ORGANIZATION<|>Nutrición Artificial refers to the medical practice of providing nutrition to patients who cannot obtain it by mouth, often used in the treatment of various medical conditions including hiponatremia.)\n##\n(\"entity\"<|>EDEMA CEREBRAL<|>EVENT<|>Edema cerebral is the swelling of the brain due to excess fluid, which can be a complication of severe hiponatremia and requires immediate treatment.)\n##\n(\"entity\"<|>SOLUCIÓN SALINA HIPERTÓNICA<|>ORGANIZATION<|>Solución Salina Hipertónica is a medical treatment used to correct severe hyponatremia by providing a high concentration of sodium to help reduce cerebral edema.)\n##\n(\"entity\"<|>SÍNDROME DE DESMIELINIZACIÓN OSMÓTICA<|>EVENT<|>Síndrome de desmielinización osmótica is a serious neurological condition that can occur as a complication of rapid correction of chronic hyponatremia.)\n##\n(\"entity\"<|>PACIENTES<|>PERSON<|>Pacientes refers to individuals receiving medical treatment for conditions such as hyponatremia, particularly those requiring artificial nutrition.)\n##\n(\"relationship\"<|>NUTRICIÓN ARTIFICIAL<|>PACIENTES<|>NUTRICIÓN ARTIFICIAL is utilized for PACIENTES who cannot obtain nutrition orally, especially in the context of treating conditions like hyponatremia.<|>8)\n##\n(\"relationship\"<|>HIPONATREMIA<|>EDEMA CEREBRAL<|>Severe HIPONATREMIA can lead to EDema cerebral, necessitating immediate medical intervention.<|>9)\n##\n(\"relationship\"<|>SOLUCIÓN SALINA HIPERTÓNICA<|>HIPONATREMIA<|>SOLUCIÓN SALINA HIPERTÓNICA is administered to treat severe HIPONATREMIA and reduce associated complications like edema cerebral.<|>9)\n##\n(\"relationship\"<|>HIPONATREMIA<|>SÍNDROME DE DESMIELINIZACIÓN OSMÓTICA<|>Improper treatment of HIPONATREMIA can lead to SÍNDROME DE DESMIELINIZACIÓN OSMÓTICA, highlighting the need for careful management.<|>7)\n##\n(\"relationship\"<|>PACIENTES<|>HIPONATREMIA<|>PACIENTES may experience HIPONATREMIA, requiring specific treatment protocols to manage their condition effectively.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 5. Tratamiento de la hiponatremia en nutrición artificial\n\nEl objetivo del tratamiento de la hiponatremia varía en función de la gravedad neurológica de la misma. En pacientes con hiponatremia grave (disminución del ni-vel de conciencia, confusión, convulsiones, etc.) el prin-cipal objetivo es revertir la clínica neurológica del pa-ciente39, 45. Sin embargo, en pacientes sin clínica neurológica grave el objetivo es corregir la hiponatre-mia franca (natremia < 135 mmol/l)45 y si es posible alcanzar cifras en torno a 138-142 mmol/l39. Este rango de natremia se ha asociado con una menor mortalidad intrahospitalaria14. Para lograr una corrección eficaz de la hiponatremia, el tratamiento debe ajustarse al tipo y etiología de la misma (tratamiento adecuado), tanto en pacientes sin nutrición artificial39, 45 como en pacientes con dicho soporte39. En un estudio prospectivo realiza-\n\ndo en 20 pacientes con NP se objetivó un incremento significativo de la natremia a las 72 horas de la adminis-tración del tratamiento adecuado, alcanzando la euna-tremia hasta el 75% de los pacientes61.\n\nLa utilización de fórmulas de cálculo de déficit de sodio para el tratamiento de la hiponatremia no es re-comendable, ya que inducen errores terapéuticos im-portantes. Esto tiene sentido, ya que la elevación de la ADH hace que haya un exceso relativo de agua versus sodio63, 64. Y en la hiponatremia euvolémica el proble-ma es exclusivamente de agua.\n\nExisten dos tipos de abordajes en el tratamiento de la hiponatremia; uno para los pacientes con clínica neurológica grave (natremia < 120 mmol/l) y otro para los pacientes sin clínica neurológica grave (natremia > 120 mmol/l). Por lo tanto, el primer paso en el trata-miento de la hiponatremia es la valoración de la clínica neurológica (figura 3), seguido de la volemia clínica y el estudio analítico39, 45, 65.\n\n### 5.1. Manejo de la hiponatremia grave en pacientes con nutrición artificial\n\nEl tratamiento de la hiponatremia grave no debe de-morarse; su finalidad es mejorar la clínica neurológica de\n---\nTema 51. Metabolismo hídrico en los pacientes con nutrición artificial... 807\n\nforma inmediata a través de la disminución del edema cerebral. Se ha demostrado que un incremento precoz de 4 a 6 mmol/l en la natremia reduce en un 50% el edema cerebral. Para ello, es necesario administrar una solución salina hipertónica (SSH) al 3%, con la suficiente osmolaridad como para mover agua del interior celular al espacio extracelular66. Esta solución hipertónica se puede pautar en forma de bolos (100 ml cada 10 min, máximo 3) o en perfusión continua (ritmo de 0,5 a 2 ml/kg/h, en función de la gravedad)45, 65. Durante su administración se debe monitorizar la clínica neurológica y los niveles de natremia cada 2 horas, retirándose tras obtener una mejoría significativa de la clínica neurológica y/o un incremento en la natremia igual o superior a 6 mmol/l. Posteriormente es recomendable realizar una natremia cada 6-8 horas y a las 24 horas postretirada para detectar un posible redescenso y una hipercorrección, respectivamente.\n\nSe considera hipercorrección al incremento de natremia que supera el límite máximo de subida en las primeras 24-48 horas. Este límite debe tenerse en cuenta únicamente en los pacientes con hiponatremia crónica (duración mayor de 48 horas y/o desconocimiento de su comienzo), ya que presentan mayor riesgo de desarrollo de síndrome de desmielinización osmótica (SDO) ante una subida moderada de la natremia45. Este riesgo depende del incremento de natremia a las 24 y 48 horas, y no de la subida en las primeras 6 horas ni del tipo de terapia utilizada. El límite máximo de elevación de la natremia debe establecerse en base al grado de riesgo de SDO: bajo o alto (pacientes desnutridos, alcohólicos, hipopotasemia o cirrosis avanzada). De forma que, en pacientes con riesgo elevado de SDO, las últimas guías recomiendan un incremento máximo de natremia en las primeras 24 horas y a diario, de\n\n| LEVES | MODERADOS | SEVEROS |\n|-------|------------|---------|\n| · Cefalea<br>· Déficit de atención<br>· Alt. memoria<br>· Marcha inestable<br\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}